< path d="M52.6178 31.3114L44.7476 60.6733L74.1095 68.5435L81.9797 39.1816L52.6178 31.3114Z" fill="#F9C32D"/>

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy TC BioPharm stock in Canada

Own TC BioPharm shares in just a few minutes.

Updated . What changed?
Fact checked

TC BioPharm is a biotechnology business based in the US. TC BioPharm stocks (TCBP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.87 – a decrease of 22.32% over the previous week. TC BioPharm employs 0 staff and has a trailing 12-month revenue of around $2 million.

How to buy stocks in TC BioPharm

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TCBP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

What's in this guide?

  1. Can I buy shares in TC BioPharm?
  2. TC BioPharm shares summary
  3. Compare share dealing platforms
  4. Is TC BioPharm stock a buy or sell?
  5. TC BioPharm performance over time
  6. TC BioPharm's financials
  7. Does TC BioPharm pay a dividend?
  8. Other common questions

TC BioPharm stock price (NASDAQ:TCBP)

Use our graph to track the performance of TCBP stocks over time.

TC BioPharm shares at a glance

Information last updated 2022-05-23.
Latest market close$0.87
52-week range$0.00 - $4.25
50-day moving average $1.26
200-day moving average $1.27
Wall St. target price$5.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.87

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Go to site
More Info
Wealthsimple Trade
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Go to site
More Info
Scotia iTRADE
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Go to site
More Info
Interactive Brokers
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Go to site
More Info
Questrade
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Go to site
More Info
Qtrade Direct Investing
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.
Go to site
More Info
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy TC BioPharm stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

TC BioPharm price performance over time

Historical closes compared with the close of $0.87 from 2022-05-26

1 week (2022-05-20) -22.32%
1 month (2022-04-28) -37.41%
3 months (2022-02-28) -12.56%
6 months (2021-11-24) N/A
1 year (2021-05-24) N/A
2 years (2020-05-24) N/A
3 years (2019-05-24) N/A
5 years (2017-05-24) N/A

TC BioPharm financials

Revenue TTM $2 million
Gross profit TTM $2 million
Return on assets TTM -59.57%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $31.4 million

TTM: trailing 12 months

TC BioPharm share dividends

We're not expecting TC BioPharm to pay a dividend over the next 12 months.

TC BioPharm overview

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. .

TC BioPharm in the news

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site